Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Dorothy E Puhy. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Dorothy E Puhy har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:MDXG / MiMedx Group, Inc. | Director | 57 597 |
US:AZTA / Azenta, Inc. | Director | 3 604 |
US:US003CVR0169 / CONTRA ABIOMED INC | Director | 0 |
US:278265AC7 / Eaton Vance 6.5% Senior Notes 10/2/17 | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Dorothy E Puhy. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp MDXG / MiMedx Group, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i MDXG / MiMedx Group, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i MDXG / MiMedx Group, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Dorothy E Puhy som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-23 |
|
4 | MDXG |
MIMEDX GROUP, INC.
Common Stock |
A - Award | 28 609 | 57 597 | 98,69 | 6,47 | 185 100 | 372 653 | |
2024-06-06 |
|
4 | MDXG |
MIMEDX GROUP, INC.
Common Stock |
A - Award | 28 988 | 28 988 | 7,26 | 210 453 | 210 453 | ||
2023-02-15 |
|
4 | AZTA |
Azenta, Inc.
Common |
A - Award | 3 604 | 3 604 | |||||
2022-12-27 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | −11 335 | 0 | −100,00 | ||||
2022-12-27 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | −3 255 | 0 | −100,00 | ||||
2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −263 | 3 633 | −6,75 | 293,34 | −77 148 | 1 065 704 | |
2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 681 | 3 896 | 21,18 | ||||
2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −279 | 3 215 | −7,99 | 319,88 | −89 247 | 1 028 414 | |
2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 625 | 3 494 | 21,78 | ||||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Phantom Stock |
D - Sale to Issuer | −3 252 | 0 | −100,00 | 73,00 | −237 396 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | −5 737 | 0 | −100,00 | 36,29 | −208 196 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | −7 451 | 0 | −100,00 | 36,24 | −270 024 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | −5 680 | 0 | −100,00 | 44,77 | −254 311 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Deferred Stock |
D - Sale to Issuer | −9 372 | 0 | −100,00 | 73,00 | −684 156 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −23 981 | 0 | −100,00 | ||||
2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 3 252 | 0,53 | ||||
2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 50 | 9 372 | 0,54 | ||||
2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −201 | 2 869 | −6,55 | 353,07 | −70 967 | 1 012 958 |
2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 304 | 3 070 | −29,81 | 351,97 | −458 969 | 1 080 548 |
2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 649 | 4 374 | −27,38 | 351,34 | −579 360 | 1 536 761 |
2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 846 | 6 023 | −23,46 | 345,64 | −638 051 | 2 081 790 |
2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 193 | 3 235 | 6,34 | ||||
2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 557 | 9 322 | 6,35 | ||||
2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 19 | 3 042 | 0,63 | ||||
2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 40 | 8 765 | 0,46 | ||||
2020-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 2 317 | 8 725 | 36,16 | ||||
2020-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 661 | 7 869 | 9,17 | ||||
2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 30 | 3 023 | 1,00 | ||||
2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 63 | 6 408 | 0,99 | ||||
2020-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −444 | 7 208 | −5,80 | 314,98 | −139 851 | 2 270 376 | |
2020-07-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −7 500 | 7 652 | −49,50 | 275,00 | −2 062 500 | 2 104 300 |
2020-06-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −7 500 | 15 152 | −33,11 | 250,00 | −1 875 000 | 3 788 000 |
2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 34 | 2 993 | 1,15 | ||||
2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 72 | 6 345 | 1,15 | ||||
2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 959 | 0,82 | ||||
2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 51 | 6 273 | 0,82 | ||||
2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 26 | 2 935 | 0,89 | ||||
2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 28 | 6 222 | 0,45 | ||||
2019-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 034 | 6 194 | 96,01 | ||||
2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 909 | 0,83 | ||||
2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 26 | 3 160 | 0,83 | ||||
2019-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −224 | 22 652 | −0,98 | 189,93 | −42 544 | 4 302 294 | |
2019-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 053 | 22 876 | 4,83 | ||||
2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 25 | 2 885 | 0,87 | ||||
2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 27 | 3 134 | 0,87 | ||||
2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 27 | 2 860 | 0,95 | ||||
2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 30 | 3 107 | 0,97 | ||||
2018-11-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 22 | 2 833 | 0,78 | ||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −2 112 | 0 | −100,00 | ||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 112 | 0,76 | ||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 077 | 3 077 | |||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −2 112 | 23 981 | −8,09 | 45,50 | −96 096 | 1 091 136 | |
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 112 | 26 093 | 8,81 | ||||
2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 096 | 0,58 | ||||
2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 2 811 | 0,61 | ||||
2018-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −541 | 21 823 | −2,42 | 376,01 | −203 421 | 8 205 666 | |
2018-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 531 | 22 364 | 2,43 | ||||
2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 084 | 0,58 | ||||
2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 794 | 0,58 | ||||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | −13 500 | 0 | −100,00 | |||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −300 | 33 168 | −0,90 | 351,97 | −105 591 | 11 674 141 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −900 | 33 468 | −2,62 | 351,06 | −315 953 | 11 749 239 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −700 | 34 368 | −2,00 | 349,98 | −244 986 | 12 028 113 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −4 195 | 35 068 | −10,68 | 349,07 | −1 464 351 | 12 241 208 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 500 | 39 263 | −3,68 | 348,07 | −522 108 | 13 666 351 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 012 | 40 763 | −6,88 | 347,07 | −1 045 367 | 14 147 513 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 664 | 43 775 | −3,66 | 346,20 | −576 077 | 15 154 905 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 229 | 45 439 | −2,63 | 345,10 | −424 132 | 15 681 162 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 46 668 | 40,70 | 9,99 | 134 865 | 466 213 |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | 11 335 | 11 335 | |||||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −11 335 | 21 833 | −34,17 | ||||
2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 072 | 0,53 | ||||
2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 778 | 0,54 | ||||
2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −11 777 | 0 | −100,00 | ||||
2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −4 045 | 0 | −100,00 | ||||
2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −9 490 | 23 981 | −28,35 | 60,49 | −574 050 | 1 450 611 | |
2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 045 | 33 471 | 13,75 | 41,90 | 169 486 | 1 402 435 | |
2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 11 777 | 29 426 | 66,73 | 34,84 | 410 311 | 1 025 202 | |
2017-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 061 | 0,63 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 587 | 0 | −100,00 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 587 | 0,63 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 587 | 17 649 | −8,25 | 51,04 | −81 000 | 900 805 | |
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 587 | 19 236 | 8,99 | ||||
2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 381 | 1 381 | |||||
2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 808 | 6 808 | |||||
2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | −13 500 | 0 | −100,00 | |||
2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −2 700 | 33 168 | −7,53 | 179,49 | −484 613 | 5 953 205 |
2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 664 | 35 868 | −9,27 | 178,77 | −655 024 | 6 412 230 |
2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 39 532 | 51,86 | 7,67 | 103 545 | 303 210 |
2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −6 420 | 0 | −100,00 | ||||
2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −4 902 | 0 | −100,00 | ||||
2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −5 953 | 17 649 | −25,22 | 51,08 | −304 105 | 901 587 | |
2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 902 | 23 602 | 26,21 | 28,68 | 140 614 | 677 023 | |
2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 420 | 18 700 | 52,28 | 24,46 | 157 030 | 457 393 | |
2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −6 865 | 0 | −100,00 | ||||
2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −6 495 | 12 280 | −34,59 | 49,38 | −320 696 | 606 335 | |
2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 865 | 18 775 | 57,64 | 47,23 | 324 237 | 886 753 | |
2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 577 | 0,64 | ||||
2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 048 | 0,59 | ||||
2017-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 283 | 26 032 | 5,18 | ||||
2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −4 883 | 0 | −100,00 | ||||
2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −2 563 | 11 910 | −17,71 | 48,46 | −124 195 | 577 120 | |
2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 883 | 14 473 | 50,92 | 27,50 | 134 258 | 397 935 | |
2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 567 | 0,71 | ||||
2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 036 | 0,69 | ||||
2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | −13 500 | 0 | −100,00 | |||
2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 111 | 24 749 | −4,30 | 132,50 | −147 211 | 3 279 322 |
2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −5 758 | 25 860 | −18,21 | 131,42 | −756 709 | 3 398 488 |
2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −6 631 | 31 618 | −17,34 | 130,63 | −866 236 | 4 130 395 |
2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 38 249 | 54,55 | 18,63 | 251 505 | 712 579 |
2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 556 | 0,65 | ||||
2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 022 | 0,65 | ||||
2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Stock option (right to buy) |
M - Exercise | X | −8 000 | 0 | −100,00 | |||
2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −8 000 | 24 749 | −24,43 | 120,00 | −960 000 | 2 969 880 |
2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 8 000 | 32 749 | 32,32 | 12,69 | 101 520 | 415 585 |
2016-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 546 | 0,78 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 448 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 448 | 0,77 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 448 | 9 590 | −13,12 | 34,99 | −50 666 | 335 554 | |
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 448 | 11 038 | 15,10 | ||||
2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 2 009 | 2 009 | |||||
2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 11 777 | 11 777 | |||||
2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −8 197 | 0 | −100,00 | ||||
2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −6 197 | 9 590 | −39,25 | 38,75 | −240 123 | 371 596 | |
2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 8 197 | 15 787 | 108,00 | 29,39 | 240 898 | 463 956 | |
2016-08-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −5 160 | 24 749 | −17,25 | 123,94 | −639 540 | 3 067 436 |
2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −300 | 29 911 | −0,99 | 123,70 | −37 110 | 3 699 991 |
2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −600 | 30 211 | −1,95 | 122,99 | −73 792 | 3 715 551 |
2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 000 | 30 811 | −8,87 | 122,03 | −366 094 | 3 759 906 |
2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 621 | 33 811 | 5,04 | ||||
2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 426 | 0,78 | ||||
2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 523 | 0,79 | ||||
2016-04-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −10 000 | 32 190 | −23,70 | 100,00 | −1 000 000 | 3 219 000 |
2016-04-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −5 602 | 42 190 | −11,72 | 95,02 | −532 320 | 4 009 029 |
2016-04-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −4 398 | 47 792 | −8,43 | 95,01 | −417 874 | 4 540 933 |
2016-03-23 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −10 000 | 52 190 | −16,08 | 90,30 | −903 035 | 4 712 940 |
2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −4 000 | 62 190 | −6,04 | 85,00 | −340 000 | 5 286 150 |
2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 4 000 | 66 190 | 6,43 | 13,21 | 52 840 | 874 370 |
2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −5 840 | 0 | −100,00 | ||||
2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −2 500 | 7 590 | −24,78 | 30,18 | −75 450 | 229 067 | |
2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 840 | 10 090 | 137,41 | 27,32 | 159 545 | 275 652 | |
2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 415 | 1,00 | ||||
2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 1 511 | 1,00 | ||||
2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | −4 000 | 4 000 | −50,00 | |||
2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −4 000 | 62 190 | −6,04 | 80,47 | −321 898 | 5 004 709 |
2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 4 000 | 66 190 | 6,43 | 13,21 | 52 840 | 874 370 | |
2015-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 401 | 0,79 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 496 | 1 496 | |||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 7 451 | 7 451 | |||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 259 | 0 | −100,00 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 259 | 0,80 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 259 | 4 250 | −22,85 | 36,11 | −45 462 | 153 468 | |
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 259 | 5 509 | 29,62 | ||||
2015-08-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −2 580 | 62 190 | −3,98 | 103,91 | −268 088 | 6 462 163 |
2015-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −2 580 | 64 770 | −3,83 | 105,27 | −271 597 | 6 818 338 |
2015-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 3 900 | 67 350 | 6,15 | ||||
2015-08-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 778 | 63 450 | −2,73 | 97,69 | −173 693 | 6 198 430 |
2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 390 | 0,72 | ||||
2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 249 | 0,73 | ||||
2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 380 | 0,66 | ||||
2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 240 | 0,65 | ||||
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −19 | 65 228 | −0,03 | 69,81 | −1 326 | 4 553 560 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −174 | 65 247 | −0,27 | 69,03 | −12 011 | 4 504 040 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −737 | 65 421 | −1,11 | 67,88 | −50 026 | 4 440 620 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 301 | 66 158 | −1,93 | 67,33 | −87 601 | 4 454 656 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −510 | 67 459 | −0,75 | 66,33 | −33 829 | 4 474 582 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −971 | 67 969 | −1,41 | 65,13 | −63 240 | 4 426 760 |
2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −864 | 68 940 | −1,24 | 64,16 | −55 434 | 4 423 177 |
2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −22 | 69 804 | −0,03 | 73,78 | −1 623 | 5 149 881 |
2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −128 | 69 826 | −0,18 | 73,00 | −9 344 | 5 097 500 |
2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −260 | 69 954 | −0,37 | 71,85 | −18 681 | 5 026 307 |
2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −403 | 70 214 | −0,57 | 70,81 | −28 536 | 4 971 790 |
2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −2 611 | 70 617 | −3,57 | 70,00 | −182 762 | 4 942 985 |
2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 371 | 0,66 | ||||
2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 232 | 0,65 | ||||
2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −8 000 | 0 | −100,00 | ||||
2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 572 | 73 228 | −2,10 | 51,93 | −81 634 | 3 802 730 | |
2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 74 800 | 11,98 | 10,06 | 80 480 | 752 488 | |
2014-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 224 | 0,74 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 362 | 1 362 | |||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 737 | 5 737 | |||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 870 | 0 | −100,00 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 870 | 0,75 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 870 | 4 250 | −30,56 | 36,83 | −68 872 | 156 528 | |
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 870 | 6 120 | 44,00 | ||||
2014-08-29 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | −3 000 | 66 800 | −4,30 | 25,70 | −77 104 | 1 716 854 | |
2014-08-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 69 800 | 12,47 | ||||
2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 215 | 0,58 | ||||
2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 856 | 0,60 | ||||
2014-06-13 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −8 000 | 0 | −100,00 | ||||
2014-06-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 62 060 | 14,80 | 10,41 | 83 280 | 646 045 | |
2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 208 | 0,67 | ||||
2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 845 | 0,60 | ||||
2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 200 | 0,59 | ||||
2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 834 | 0,55 | ||||
2013-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 824 | 0,61 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 193 | 1 193 | |||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −2 167 | 0 | −100,00 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 167 | 0,56 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 045 | 4 045 | |||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −2 167 | 4 250 | −33,77 | 41,90 | −90 797 | 178 075 | |
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 167 | 6 417 | 50,99 | ||||
2013-08-16 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 54 060 | 16,71 | ||||
2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 813 | 0,50 | ||||
2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 155 | 0,51 | ||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 804 | 0,50 | ||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 144 | 0,52 | ||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 883 | 4 883 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 680 | 5 680 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 420 | 6 420 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 902 | 4 902 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 865 | 6 865 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 8 197 | 8 197 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 840 | 5 840 | |||||
2013-02-12 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | 7 000 | 0 | −100,00 | 5,40 | 37 800 | ||
2013-02-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 7 000 | 46 320 | 17,80 | 5,40 | 37 800 | 250 128 | |
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 795 | 0,62 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 55 | 1 784 | 3,18 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 133 | 0,61 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 65 | 2 120 | 3,16 | ||||
2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −5 800 | 0 | −100,00 | ||||
2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −4 050 | 4 250 | −48,80 | 31,77 | −128 675 | 135 029 | |
2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 800 | 8 300 | 232,00 | 21,99 | 127 542 | 182 517 | |
2012-11-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 055 | 0,69 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 729 | 1 729 | |||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 799 | 0 | −100,00 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 799 | 0,73 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 543 | 5 543 | 28,92 | 160 304 | 160 304 | ||
2012-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 39 320 | 15,69 | ||||
2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 041 | 0,74 | ||||
2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 786 | 0,73 | ||||
2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 026 | 0,75 | ||||
2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 773 | 0,74 | ||||
2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 011 | 0,80 | ||||
2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 760 | 0,80 | ||||
2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | 8 000 | 7 000 | −800,00 | 5,40 | 43 200 | 37 800 | |
2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −4 000 | 33 987 | −10,53 | 23,11 | −92 440 | 785 443 | |
2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 37 987 | 26,68 | 5,40 | 43 200 | 205 130 | |
2011-08-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 29 987 | 21,63 | ||||
2011-05-23 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 15 000 | −25,00 | ||||
2011-05-23 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 27 654 | 22,07 | 5,40 | 27 000 | 149 332 | |
2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 20 000 | −20,00 | ||||
2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 22 654 | 28,32 | 5,40 | 27 000 | 122 332 | |
2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 13 500 | 13 500 | |||||
2010-08-13 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 13 500 | 13 500 | |||||
2010-04-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 453 | 17 654 | 8,97 | 10,32 | 14 995 | 182 189 | |
2009-08-14 |
|
4 | ABMD |
ABIOMED INC
Stock Options (right to buy) |
A - Award | 13 500 | 13 500 | 7,67 | 103 545 | 103 545 | ||
2008-08-15 |
|
4 | ABMD |
ABIOMED INC
Stock Options (right to buy) |
A - Award | 13 500 | 13 500 | 18,63 | 251 505 | 251 505 | ||
2008-04-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 141 | 11 500 | 11,01 | 13,14 | 14 993 | 151 110 | |
2008-02-28 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2008-02-28 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 10 359 | 93,30 | 5,15 | 25 750 | 53 349 | |
2007-08-10 |
|
4 | ABMD |
ABIOMED INC
Stock option (right to buy) |
A - Award | 8 000 | 8 000 | 12,69 | 101 520 | 101 520 | ||
2007-05-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 254 | 5 359 | 30,55 | 11,96 | 14 998 | 64 094 | |
2006-08-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | 13,21 | 105 680 | 105 680 |